Healthcare Services
Allen & Overy can provide legal services creating a solid foundation for your healthcare infrastructure projects.
Development and provision of specialised healthcare infrastructure is one of the key themes in modern times and requires specialist advice. The unique issues raised by the public service nature of hospitals, nursing homes, rehabilitation centres, clinics, academic and commercial R&D facilities always challenge investors, sponsors and lenders. As a global firm, we can successfully guide you through all stages of the lifecycle of healthcare infrastructure projects. In the healthcare infrastructure sector, we regularly advise on lettings and leasings, development, planning and construction, environmental issues and implications, private/public partnerships, including public procurement, transitional employment issues, commercial agreements with stakeholders, outsourcing, data protection and privacy, strategic licensing and collaboration agreements, global joint ventures, M&A and restructuring.
Explore our sectors
Meet our lawyers
News & insights
Publications: 29 JULY 2020
A hard pill to swallow: Belgian Court of Cassation provides clarity on patient informed consent
Setting the stage Since long, discussions in Belgium have been ongoing as to who needs to prove that a patient was sufficiently informed about his/her treatment and its potential complications. With…
Read more
News: 20 JULY 2020
Advising GSK on its strategic collaboration with CureVac
An A&O team comprising UK, German, U.S. and Dutch lawyers is advising GlaxoSmithKline (GSK) on its strategic collaboration with German biotech company CureVac for the research, development and…
Read more
News: 10 JULY 2020
Allen & Overy has advised the joint sponsors on the global offering and listing of shares of Immunotech Biopharm Ltd (Immunotech Biopharm) on the Hong Kong Stock Exchange under Chapter 18A of the…
Read more
Publications: 02 SEPTEMBER 2019
China: amendment to Drug Administration Law
On August 26, 2019, the China’s National People’s Congress passed the amended Drug Administration Law (the Amended DAL) which will take effect on December 1.
Read moreDownload our sector brochure
